Skip to main content
OpenTrials
Completed

NCT Number: NCT03249246

Epidemiology of Sepsis in Turkish ICUs.

The prevalence and mortality of sepsis in Turkey is not know at large. Turkish Society of Intensive Care Medicine, Sepsis Study Group conducted a multi-centre,point prevalence survey to determine the prevalence, causative micro-organisms and outcome of sepsis in Turkish ICUs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Septic Shock Severe Sepsis Shock Shock, Septic Systemic Inflammatory Response Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients present on or admitted to participating ICU on study day.

Exclusion criteria

  • Age<18 years
  • Patients who underwent cardiovascular surgery.

Treatment and study plan

No intervention

Other

Primary outcomes

  1. Prevalence of sepsis

    Time frame: Up to 12 weeks.

    The prevalence of sepsis,Severe sepsis and septic shock on study day

Secondary outcomes

  1. Mortality rate of sepsis

    Time frame: Mortality at 30 days

    Mortality rate of septic shock

Sponsors and collaborators

Lead sponsor

Nur Baykara

Other

Collaborators

  • Turkish Society of Intensive Care, Sepsis Study Group

Registry information

Official study title

Epidemiology of Sepsis in Turkish ICUs :a National Point Prevalence Multi-centre Study.

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Aug 15, 2017
Registry last updated
Aug 15, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.